Instylla Announces Enrollment of Initial Patients in the Embra...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEDFORD, Mass., March 30, 2021 /PRNewswire-AsiaNet/ -- -- Pivotal study to evaluate the use of novel liquid embolic versusstandard of care in treating malignant and benign hypervascular tumorsInstylla, Inc. ( http://www.instylla.com/ ), a privately held company developing next-generation...
Authors: LATEST ASIANET NEWS RELEASES